In a pioneering study published in Biological Psychiatry by Elsevier, scientists have conducted the first comprehensive single-cell analysis of brain tissue from individuals with Tourette syndrome. The findings offer unprecedented clarity into which specific brain cells are affected by the condition and how they malfunction—offering the most detailed cellular map of the syndrome to date. Conducted by researchers at Yale University, the Mayo Clinic, and the National Human Genome Research Institute (NHGRI), the study could mark a turning point in how Tourette syndrome is understood and treated.
Shedding Light on a Complex Neurological Disorder
Tourette syndrome is a complex neuropsychiatric disorder marked by involuntary motor and vocal tics such as eye blinking, throat clearing, and other repetitive behaviors. Affecting approximately 1 in 150 children, it remains one of the least understood conditions in psychiatry—particularly in terms of its underlying biological mechanisms.
While previous research had identified structural changes in the brain and some associated risk genes, it lacked the precision required to map changes at a single-cell level. This latest study addresses that gap.
Key Cellular Findings: Interneurons, Neuronal Stress, and Inflammation
Using advanced single-cell RNA sequencing, the researchers analyzed post-mortem brain tissue from six individuals diagnosed with severe Tourette syndrome and compared it with tissue from six matched controls. The region of focus was the caudate-putamen—a central area within the basal ganglia, known to regulate motor function and implicated in prior Tourette studies.
READ MORE: Scientists Discover Early Signs of T Cell Exhaustion in Initial Stages of Infection
The research uncovered three significant abnormalities in individuals with Tourette syndrome:
Drastic Loss of Interneurons
The number of interneurons—a specialized class of inhibitory neurons that modulate brain activity—was reduced by around 50% in the caudate-putamen.
Interneurons normally help regulate excitatory signals in the brain. Their loss is believed to contribute to the hyperactivity of neural circuits that manifest as involuntary tics and vocalizations.
Metabolic Stress in Medium Spiny Neurons
The medium spiny neurons (MSNs), which serve as the primary long-range projection neurons in this region, showed decreased activity in mitochondrial genes.
These changes indicate cellular stress and impaired energy metabolism, potentially undermining the neurons’ ability to function and communicate effectively.
Elevated Inflammatory Activity in Microglia
Microglia, the brain’s immune cells, exhibited markers of inflammation, a finding not previously well-characterized in Tourette syndrome.
Interestingly, this immune activation was strongly correlated with the metabolic stress in MSNs, suggesting a novel form of cellular communication or mutual disruption.
A Holistic View of Cellular Dysfunction
“These results are extremely compelling,” said Dr. Flora M. Vaccarino, senior author of the study and professor at the Yale Child Study Center. “They provide a roadmap of exactly how specific brain cells are affected in Tourette syndrome—not only in their abundance but also in their metabolic and immune functioning.”
Dr. Vaccarino, a leading expert in developmental neuroscience, highlighted how this new cellular understanding builds on her lab’s earlier findings. “While we knew from imaging and earlier post-mortem studies that the caudate-putamen is structurally smaller in Tourette patients and harbors fewer interneurons, we didn’t know how each individual cell type was behaving at a molecular level. Now, we do.”
Epigenetic Insights: Not Just a Matter of DNA
Another groundbreaking component of this research involved gene regulatory elements—segments of DNA that control when genes are turned on or off.
According to Dr. Yifan Wang, co-lead author from the Mayo Clinic’s Center for Individualized Medicine, “Our data suggest that Tourette syndrome may not result from mutations in protein-coding genes but from errors in the epigenetic regulation—how genes are activated or silenced. That’s a very different mechanism than what we often look for in genetic disorders.”
This suggests that developmental timing and environmental influences could play a larger role in the emergence of the condition than previously recognized.
Why the Loss of Inhibitory Interneurons Matters
The loss of inhibitory interneurons emerged as one of the most critical discoveries. These cells act like brakes in the brain, ensuring that excitatory signals don’t become overwhelming. In Tourette syndrome, the absence of these brakes could allow overactivation of motor pathways—resulting in tics.
Dr. John Krystal, Editor of Biological Psychiatry, noted the significance of this finding: “The study highlights inhibitory interneuron and synaptic loss as central to the basal ganglia dysfunction observed in Tourette syndrome. Current treatments don’t address this root cause. These findings offer a potential new therapeutic target.”
Limited Genetic Clues Prompted Deeper Investigation
Co-lead author Dr. Liana Fasching, also from Yale, explained what drove the team to pursue this more granular investigation: “Tourette syndrome has one of the highest familial recurrence rates among psychiatric disorders, yet large-scale genetic studies have only pinpointed a few risk genes. We suspected that traditional genetic methods were missing the picture and that we needed to go deeper—literally into the brain tissue—to find answers.”
New Avenues for Therapy and Prevention
By identifying precisely which brain cell types are involved and how they interact, the study opens the door to more targeted therapies. Potential strategies could include:
Cellular regeneration: Stimulating the growth or survival of interneurons in the caudate-putamen.
Metabolic intervention: Targeting mitochondrial function to reduce stress in MSNs.
Anti-inflammatory treatments: Modulating microglial activation to interrupt the harmful feedback loop between inflammation and neuronal stress.
Epigenetic therapies: Adjusting gene regulation without altering the DNA sequence.
Conservation and Broader Implications
The study’s findings may also inform other areas of neuroscience and psychiatry. The relationship between metabolic stress, immune activity, and gene regulation could have parallels in other disorders like Parkinson’s disease, schizophrenia, or autism, where overlapping brain regions and cell types are involved.
Moreover, the study reinforces the value of high-resolution single-cell analysis as a tool not just for discovery but for precision medicine. “If we understand the problem at the level of individual cells,” Dr. Wang emphasized, “we can begin to think about personalized treatments based on specific cellular dysfunction.”
A Milestone in Tourette Syndrome Research
Reflecting on two decades of research, Dr. Vaccarino said: “Our first paper on basal ganglia interneurons in Tourette syndrome was published in 2005. To come back 20 years later with this level of cellular detail is a testament to how far technology—and our understanding—has come. But there’s still much work ahead. We hope these findings will inspire new clinical trials and support for people affected by this condition.”
As the research community digests these findings, there’s renewed optimism that a better understanding of the biology behind Tourette syndrome will finally translate into more effective, tailored treatments. This study is not just a scientific milestone—it’s a leap forward in the pursuit of improved quality of life for thousands living with this often-misunderstood disorder.
